113 related articles for article (PubMed ID: 27729673)
1. Gefitinib and Sonidegib.
Medler CJ; Waddell JA; Solimando DA
Hosp Pharm; 2015 Nov; 50(10):868-872. PubMed ID: 27729673
[TBL] [Abstract][Full Text] [Related]
2. Dinutuximab and Panobinostat.
Chasick A; Solimando DA; Waddell JA
Hosp Pharm; 2015 Oct; 50(9):767-72. PubMed ID: 26912916
[TBL] [Abstract][Full Text] [Related]
3. Blinatumomab and Pembrolizumab.
Tabor EE; Waddell JA; Solimando DA
Hosp Pharm; 2015 Apr; 50(4):269-73. PubMed ID: 26448656
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel, Carboplatin, and trastuzumab.
Lee J; Solimando DA; Waddell JA
Hosp Pharm; 2014 Nov; 49(10):913-9. PubMed ID: 25477563
[TBL] [Abstract][Full Text] [Related]
5. Alectinib, Ceritinib, Elotuzumab, and Venetoclax.
Waddell JA; Solimando DA
Hosp Pharm; 2016 Jul; 51(7):524-34. PubMed ID: 27559185
[TBL] [Abstract][Full Text] [Related]
6. Drug Monographs: Ixazomib and Necitumumab.
Lawson FE; Waddell JA; Solimando DA
Hosp Pharm; 2016 May; 51(5):362-6. PubMed ID: 27303088
[TBL] [Abstract][Full Text] [Related]
7. Carboplatin and Liposomal Doxorubicin for Ovarian Cancer.
Nguyen J; Solimando DA; Waddell JA
Hosp Pharm; 2016 Jun; 51(6):442-9. PubMed ID: 27354744
[TBL] [Abstract][Full Text] [Related]
8. Drug Monographs: Avelumab and Ribociclib.
Waddell JA; Solimando DA
Hosp Pharm; 2017 Jul; 52(7):459-463. PubMed ID: 29276273
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin and Dacarbazine (AD) Regimen for Soft Tissue Sarcomas.
Adkins KE; Solimando DA; Waddell JA
Hosp Pharm; 2015 Mar; 50(3):194-8. PubMed ID: 26405307
[TBL] [Abstract][Full Text] [Related]
10. Gefitinib, Fluorouracil, Oxaliplatin, and Leucovorin (IFOX) Regimen for Colorectal Cancer.
Chen AS; Solimando DA; Waddell JA
Hosp Pharm; 2013 Dec; 48(11):905-11. PubMed ID: 24474830
[TBL] [Abstract][Full Text] [Related]
11. Gemcitabine and Carboplatin (renally dosed) regimen for bladder cancer.
Ryan Pritchard E; Waddell JA; Solimando DA
Hosp Pharm; 2015 Feb; 50(2):103-7. PubMed ID: 25717204
[TBL] [Abstract][Full Text] [Related]
12. Enzalutamide and ruxolitinib.
Hobson SA; Waddell JA; Solimando DA
Hosp Pharm; 2013 Feb; 48(2):104-7. PubMed ID: 24421446
[TBL] [Abstract][Full Text] [Related]
13. Lenvatinib and Palbociclib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 Jul; 50(7):578-82. PubMed ID: 26448668
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab and Olaparib.
Solimando DA; Waddell JA
Hosp Pharm; 2015 May; 50(5):356-66. PubMed ID: 26405320
[TBL] [Abstract][Full Text] [Related]
15. Nab-Paclitaxel and Carboplatin (Nab-PC) Regimen for Advanced Non-Small-Cell Lung Cancer.
Mancheril BG; Waddell JA; Solimando DA
Hosp Pharm; 2014 Oct; 49(9):804-8. PubMed ID: 25477610
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and trastuzumab for breast cancer.
Lehmann T; Solimando DA; Waddell JA
Hosp Pharm; 2014 Apr; 49(4):338-44. PubMed ID: 24958939
[TBL] [Abstract][Full Text] [Related]
17. Irinotecan and Carboplatin (IC) Regimen for Small-Cell Lung Cancer and Non-Small-Cell Lung Cancer.
Rutledge MR; Waddell JA; Solimando DA
Hosp Pharm; 2014 Jul; 49(7):603-11. PubMed ID: 25477577
[TBL] [Abstract][Full Text] [Related]
18. Drug monographs: dabrafenib and trametinib.
Waddell JA; Solimando DA
Hosp Pharm; 2013 Nov; 48(10):818-21. PubMed ID: 24421433
[TBL] [Abstract][Full Text] [Related]
19. Drug monographs: belinostat and idelalisib.
Piper WL; Waddell JA; Solimando DA
Hosp Pharm; 2014 Dec; 49(11):1009-13. PubMed ID: 25673888
[TBL] [Abstract][Full Text] [Related]
20. Drug monographs: pomalidomide and ponatinib.
Butler TW; Waddell JA; Solimando DA
Hosp Pharm; 2013 Sep; 48(8):636-41. PubMed ID: 24421531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
